| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/26/1997 | EP0759087A1 Compositions and methods for targeting gene delivery vehicles |
| 02/26/1997 | EP0759083A1 Methods of inducing gene expression by ionizing radiation |
| 02/26/1997 | EP0759082A1 Dna construct for effecting homologous recombination and uses thereof |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0759077A1 Lanthionine-containing antimicrobial compound |
| 02/26/1997 | EP0759075A1 Apoptosis regulating gene |
| 02/26/1997 | EP0759069A1 Beta taipoxin as a cell growth factor and method |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |
| 02/26/1997 | EP0759037A1 Antigen/antibody specificity exchanger |
| 02/26/1997 | EP0759036A1 Immunointeractive molecules-i |
| 02/26/1997 | EP0759035A1 Methods for controlling t lymphocyte mediated immune responses |
| 02/26/1997 | EP0759034A1 Peptides for diagnostics and therapeutics |
| 02/26/1997 | EP0759032A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
| 02/26/1997 | EP0759029A1 Modified milk growth factor |
| 02/26/1997 | EP0758906A1 Pegylation reagents and compounds formed therewith |
| 02/26/1997 | EP0758905A1 Pharmaceutical compositions comprising hirudin |
| 02/26/1997 | EP0758904A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
| 02/26/1997 | EP0758903A1 Cryoprecipitated native fibrinogen concentrates |
| 02/26/1997 | EP0758902A1 Compositions and treatment for multiple sclerosis |
| 02/26/1997 | EP0758901A1 Formulations for il-11 |
| 02/26/1997 | EP0758900A1 Method for reduction of headache pain |
| 02/26/1997 | EP0758899A1 Permeabilizer peptides for increasing blood-ocular barrier permeability |
| 02/26/1997 | EP0758898A1 Activin antagonists as novel contraceptives |
| 02/26/1997 | EP0758893A1 Potentiated antibiotic composition |
| 02/26/1997 | EP0758887A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical |
| 02/26/1997 | EP0758843A1 Modified amino acids for drug delivery |
| 02/26/1997 | EP0726911A4 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 02/26/1997 | EP0702558A4 Novel opioid peptide inhibitors |
| 02/26/1997 | EP0630382B1 Lactam dipeptides having hle inhibiting activity |
| 02/26/1997 | EP0541753B1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT |
| 02/26/1997 | EP0519976B1 Neutrophil stimulating peptides |
| 02/26/1997 | CN1143978A Antimicrobial proteins from aralia and impatiens |
| 02/26/1997 | CN1143969A Compositions and methods using unbound mpl receptor for stimulating platelet production |
| 02/26/1997 | CN1143968A Peptides inhibiting release of pepsine |
| 02/26/1997 | CN1143967A Method for variation of chromatin condensation |
| 02/26/1997 | CN1143911A Stabilized composition for oral administration of peptides |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/26/1997 | CN1143647A Dipeptides which promote release of growth hormone |
| 02/26/1997 | CN1143496A Improving tolerability of pharmaceutically active beta-amino acids |
| 02/26/1997 | CN1034123C Calcium channel blocking polypeptides from filistate hibernalis |
| 02/26/1997 | CN1034105C Nasal formulations and process for preparation |
| 02/25/1997 | USRE35465 Method and agents for removing advanced glycosylation endproducts |
| 02/25/1997 | US5606086 Heat resistant carbonate-and/or bicarbonate-iron-lactoferrin complex |
| 02/25/1997 | US5606047 Includes polynucleotide duplexes that have significant binding activity for lupus antibodies |
| 02/25/1997 | US5606044 Using nucleic acid probes |
| 02/25/1997 | US5606043 Methods for the diagnosis of glaucoma |
| 02/25/1997 | US5606042 Dna sequence |
| 02/25/1997 | US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification |
| 02/25/1997 | US5606031 Expressing gene coding for neurotrophic factor in bacteria, solubilizing, sulfonylating, isolating and purifying by anion exchange chromatography, allowing to refold, purifying by cation exchange chromatography |
| 02/25/1997 | US5606030 Coconjugates of OMPC, HIV related peptides and anionic moieties |
| 02/25/1997 | US5606027 Antibodies to a neutrophil chemotactic protein |
| 02/25/1997 | US5606026 Natural human IgM antibodies immunoreactive with the Tat protein of HIV-1 |
| 02/25/1997 | US5606025 Hemoglobin-enzyme complexes |
| 02/25/1997 | US5606024 Canine G-CSF polypeptides and pharmaceutical compositions comprising same |
| 02/25/1997 | US5606023 Reduced toxicity |
| 02/25/1997 | US5606020 6 (R)-l-erythro-5,6,7,8-tetrahydrobiopterin receptor |
| 02/25/1997 | US5606019 Synthetic proteins having alternating blocks of fibroin and elastin repeating units; bioresorbable |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605926 Trifluoromethyl-containing pseudopeptides active against retroviruses |
| 02/25/1997 | US5605893 Mixture of carbohydrates, protein and fats |
| 02/25/1997 | US5605887 Therapeutic fibrinogen compositions |
| 02/25/1997 | US5605886 Anti-obesity proteins |
| 02/25/1997 | US5605885 Administeration of prolactin agonist to immunosuppressed animal or human |
| 02/25/1997 | US5605884 Mixture with sodium or potassium chloride, calcium chloride and histidine buffer |
| 02/25/1997 | US5605831 Human melanoma cell specific antigens and antibodies |
| 02/25/1997 | US5605830 Cancer diagnosis, therapy |
| 02/25/1997 | US5605828 Contacting cells with fk-506 rapamycin to inhibit viral replication; immunosuppressants |
| 02/25/1997 | US5605826 Preparing cytoplasmic extract of mammalian cells pretreated with apoptosis inducing agent, isolating protease using affinity column having immobilized protease inhibitor, purifying apoptotic protease using heparin-sepharose column |
| 02/25/1997 | US5605825 Human PAK65 |
| 02/25/1997 | US5605821 Expression control sequences of the P-selectin gene |
| 02/25/1997 | US5605815 Useful in detection of cancers |
| 02/25/1997 | US5605814 DNA encoding human prostaglandin receptor EP2 |
| 02/25/1997 | US5605809 Reagents comprising characteristically folded peptide backbone each end of which is conjugated to a fluorophore |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605803 Human sperm diagnostic |
| 02/25/1997 | US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites |
| 02/25/1997 | US5605793 Adding to cleaved random double stranded fragments one or more single stranded or double stranded oligonucleotides, denaturing into single stranded fragments, incubating |
| 02/25/1997 | US5605696 Drug loaded polymeric material and method of manufacture |
| 02/25/1997 | US5605690 Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor |
| 02/25/1997 | US5605689 Treatment of HIV-associated immune thrombocytopenic purpura |
| 02/25/1997 | US5605688 Recombinant dog and horse type I interferons |
| 02/25/1997 | CA2078805C Cytokine preparation |
| 02/25/1997 | CA2077991C Cosmetics and pharmaceuticals containing extensins and related methods |
| 02/25/1997 | CA1338949C Nikkomycin derivatives |
| 02/25/1997 | CA1338948C Composition for macrophage activation |
| 02/20/1997 | WO1997006271A1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 02/20/1997 | WO1997006263A1 Hybrid protein comprising t-helper cell stimulating epitopes and b-cell epitopes from the major outer membrane protein of chlamydia trachomatis and its use as a vaccine |
| 02/20/1997 | WO1997006262A1 Non-receptor type human protein tyrosine phosphatase |
| 02/20/1997 | WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/20/1997 | WO1997006258A2 cDNA SEQUENCE, AMINO-ACID SEQUENCE, DERIVED FROM THE cDNA SEQUENCE, OF THE PRECURSOR PROTEIN OF HUMAN GCAP-II/UROGUANYLINE, AND AMINO-ACID SEQUENCE OF THE FRAGMENT CIRCULATING IN HUMAN BLOOD |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006254A1 Human mp52 arg protein |
| 02/20/1997 | WO1997006252A1 Synthetic oligonucleotides with enhanced ribonuclease activity |
| 02/20/1997 | WO1997006251A1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-α RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-α AND ITS ANALOGUES |
| 02/20/1997 | WO1997006247A2 Deubiquitinating enzymes that regulate cell growth |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997006182A1 Inhibitors of apoptosis |
| 02/20/1997 | WO1997006176A2 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 02/20/1997 | WO1997005901A1 Targeting of organs by immunoconjugates |